Alexander Nowak
Stock Analyst at Lucid Capital
(3.31)
# 2,428
Out of 5,036 analysts
338
Total ratings
40.9%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNSR LENSAR | Initiated Coverage: Buy | $11 | $6.51 | +68.97% | 1 | Sep 28, 2026 | |
| MBOT Microbot Medical | Reiterated: Buy | $3 | $1.12 | +167.86% | 1 | Sep 25, 2026 | |
| XTNT Xtant Medical Holdings | Initiated Coverage: Buy | $1 | $0.3215 | +211.04% | 1 | Sep 2, 2026 | |
| IMDX Insight Molecular Diagnostics | Initiated Coverage: Buy | $8 | $3.46 | +131.21% | 1 | Aug 24, 2026 | |
| COCH Envoy Medical | Initiated Coverage: Buy | $2 | $0.6534 | +206.09% | 1 | Jul 27, 2026 | |
| FOCL EDAP TMS | Initiated Coverage: Buy | $10 | $4.19 | +138.66% | 1 | Jun 22, 2026 | |
| HUT Hut 8 | Reiterated: Hold | $12 | $89.30 | n/a | 2 | Apr 1, 2024 | |
| CELC Celcuity | Rated: Buy | n/a | $65.78 | n/a | 16 | Mar 28, 2024 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $8 | $7.99 | n/a | 19 | Mar 20, 2024 | |
| INFU InfuSystem Holdings | Rated: Buy | n/a | $13.33 | n/a | 11 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.98 | n/a | 22 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.81 | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.13 | n/a | 11 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.84 | n/a | 21 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $63.04 | n/a | 28 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $395.56 | n/a | 27 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $168.33 | n/a | 15 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.86 | n/a | 4 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $15.97 | n/a | 17 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.31 | n/a | 27 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.11 | n/a | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $72.53 | n/a | 17 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.67 | n/a | 18 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $7.25 | n/a | 1 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.97 | n/a | 8 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.95 | n/a | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.61 | n/a | 1 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.29 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $293.26 | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $645.86 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.06 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $285.78 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.7071 | n/a | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $167.22 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $4 | $12.77 | n/a | 9 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.78 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $25.24 | n/a | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 | $1.42 | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.41 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $6.08 | n/a | 9 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $40 | $9.16 | n/a | 10 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $75.21 | n/a | 1 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $41.30 | n/a | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $27.97 | n/a | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $6.36 | n/a | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.151 | n/a | 3 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $36 | $0.000001 | n/a | 8 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $211 | $506.67 | n/a | 1 | Feb 1, 2018 |
LENSAR
Sep 28, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $6.51
Upside: +68.97%
Microbot Medical
Sep 25, 2026
Reiterated: Buy
Price Target: $3
Current: $1.12
Upside: +167.86%
Xtant Medical Holdings
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $1
Current: $0.3215
Upside: +211.04%
Insight Molecular Diagnostics
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.46
Upside: +131.21%
Envoy Medical
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.6534
Upside: +206.09%
EDAP TMS
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $4.19
Upside: +138.66%
Hut 8
Apr 1, 2024
Reiterated: Hold
Price Target: $12
Current: $89.30
Upside: n/a
Celcuity
Mar 28, 2024
Rated: Buy
Price Target: n/a
Current: $65.78
Upside: n/a
DiaMedica Therapeutics
Mar 20, 2024
Reiterated: Buy
Price Target: $8
Current: $7.99
Upside: n/a
InfuSystem Holdings
Mar 15, 2024
Rated: Buy
Price Target: n/a
Current: $13.33
Upside: n/a
Mar 14, 2024
Rated: Buy
Price Target: n/a
Current: $2.98
Upside: n/a
Mar 8, 2024
Rated: Buy
Price Target: n/a
Current: $6.81
Upside: n/a
Mar 5, 2024
Rated: Buy
Price Target: n/a
Current: $1.13
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $15.84
Upside: n/a
Feb 29, 2024
Reiterated: Hold
Price Target: n/a
Current: $63.04
Upside: n/a
Feb 29, 2024
Rated: Buy
Price Target: n/a
Current: $395.56
Upside: n/a
Feb 23, 2024
Rated: Buy
Price Target: n/a
Current: $168.33
Upside: n/a
Feb 22, 2024
Reiterated: Buy
Price Target: $20
Current: $1.86
Upside: n/a
Feb 21, 2024
Rated: Buy
Price Target: n/a
Current: $15.97
Upside: n/a
Feb 21, 2024
Downgraded: Hold
Price Target: n/a
Current: $12.31
Upside: n/a
Feb 15, 2024
Reiterated: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Feb 2, 2024
Rated: Buy
Price Target: $80
Current: $72.53
Upside: n/a
Jan 31, 2024
Rated: Buy
Price Target: n/a
Current: $1.67
Upside: n/a
Jan 29, 2024
Rated: Buy
Price Target: n/a
Current: $7.25
Upside: n/a
Jan 24, 2024
Rated: Buy
Price Target: n/a
Current: $2.97
Upside: n/a
Jan 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $39.95
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.61
Upside: n/a
Nov 2, 2023
Reiterated: Buy
Price Target: $40
Current: $27.29
Upside: n/a
Oct 11, 2023
Reiterated: Buy
Price Target: n/a
Current: $293.26
Upside: n/a
Oct 9, 2023
Rated: Buy
Price Target: n/a
Current: $645.86
Upside: n/a
Oct 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $4.06
Upside: n/a
Oct 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $285.78
Upside: n/a
Oct 3, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.7071
Upside: n/a
Oct 2, 2023
Rated: Buy
Price Target: n/a
Current: $167.22
Upside: n/a
Jul 24, 2023
Reiterated: Hold
Price Target: $2 → $4
Current: $12.77
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $10.78
Upside: n/a
Jul 14, 2023
Rated: Buy
Price Target: n/a
Current: $25.24
Upside: n/a
Jul 13, 2023
Rated: Buy
Price Target: $60
Current: $1.42
Upside: n/a
May 26, 2023
Rated: Buy
Price Target: n/a
Current: $3.41
Upside: n/a
May 12, 2023
Rated: Buy
Price Target: $8
Current: $6.08
Upside: n/a
May 9, 2023
Rated: Sell
Price Target: $40
Current: $9.16
Upside: n/a
May 2, 2023
Rated: Buy
Price Target: n/a
Current: $75.21
Upside: n/a
Apr 19, 2023
Reiterated: Buy
Price Target: $28
Current: $41.30
Upside: n/a
Feb 14, 2023
Rated: Buy
Price Target: $58
Current: $27.97
Upside: n/a
Feb 9, 2023
Rated: Buy
Price Target: $3
Current: $6.36
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $10 → $5
Current: $0.151
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $8 → $36
Current: $0.000001
Upside: n/a
Feb 1, 2018
Reiterated: Buy
Price Target: $211
Current: $506.67
Upside: n/a